Copyright
©The Author(s) 2018.
World J Clin Cases. Oct 26, 2018; 6(12): 493-500
Published online Oct 26, 2018. doi: 10.12998/wjcc.v6.i12.493
Published online Oct 26, 2018. doi: 10.12998/wjcc.v6.i12.493
Table 2 Composite of autologous bone marrow derived stem cell therapy trials
| Author | Year of study | Fistula site | Study population | Method of administration | Healing type of fistula | Safety | Outcome |
| Ciccocioppo et al[10] | 2015 | Perianal Enterocutaneous | 10 | Serial intrafistula injections of autologous bone marrow MSCs | 2 patients with no recurrence of fistula at 5 yr | No adverse events | Fistula relapse free: 88% at 1 yr, 50% at 2 yr, and 37% during the following 4 yr |
- Citation: Turse EP, Dailey FE, Naseer M, Partyka EK, Tahan V. One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy. World J Clin Cases 2018; 6(12): 493-500
- URL: https://www.wjgnet.com/2307-8960/full/v6/i12/493.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i12.493